CCM
SRRA

Chicago Capital Management’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Chicago Capital Management’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-235,395
Closed -$12.9M – 48
2022
Q2 		$12.9M Buy
+235,395
New +$12.4M 7.35% 6

Other funds holding SRRA

HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Chicago Capital Management's SRRA Position: Q3 2022 in Review

Chicago Capital Management sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 235,395 shares — an estimated $12.9M sold.

Chicago Capital Management first reported a position in SRRA in Q2 2022 and held it in 1 quarter. The position peaked at $12.9M in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

  • Chicago Capital Management reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Chicago Capital Management sold 235,395 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $12.9M.
  • Chicago Capital Management first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Chicago Capital Management's Sierra Oncology, Inc. Common Stock position peaked at $12.9M in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on Chicago Capital Management's 13F filing for Q3 2022, filed 9 Nov 2022.